Literature DB >> 10172714

Residential alternatives to hospitalization for patients with severe and persistent mental illness: should patients with comorbid substance abuse be excluded?

J M Herrell1, W Fenton, L R Mosher, S Hedlund, B Lee.   

Abstract

Residential alternatives to hospitalization for adults with severe mental illness in crisis were not designed for, and often exclude, persons with coexisting substance abuse disorders. Given high comorbidity rates, however, it is important to know whether residential alternatives can be effective for patients with dual diagnoses. To explore the impact of comorbidity on treatment outcomes, structured interviews were conducted at admission and discharge with 92 consecutive admissions to a residential alternative. Using the Structured Clinical Interview for DSM-III-R, two groups were identified: 24 patients with and 68 patients without comorbid substance abuse disorders. At admission, the two groups were similar in demographic and clinical characteristics. The treatment was effective independent of comorbidity; at discharge, treatment success, symptom improvement, and patient satisfaction were similar for both groups. Persons with coexisting substance abuse disorders remained in residence a week longer, but the difference was not statistically significant. Residential alternatives appear suitable for patients with dual diagnoses.

Entities:  

Mesh:

Year:  1996        PMID: 10172714     DOI: 10.1007/bf02522308

Source DB:  PubMed          Journal:  J Ment Health Adm        ISSN: 0092-8623


  9 in total

1.  The positive and negative syndrome scale (PANSS) for schizophrenia.

Authors:  S R Kay; A Fiszbein; L A Opler
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

2.  Crossing Place: a residential model for crisis intervention.

Authors:  M Kresky-Wolff; S Matthews; F Kalibat; L R Mosher
Journal:  Hosp Community Psychiatry       Date:  1984-01

3.  Mental hospitals and alternative care. Noninstitutionalization as potential public policy for mental patients.

Authors:  C A Kiesler
Journal:  Am Psychol       Date:  1982-04

Review 4.  Substance abuse among general psychiatric patients: place of presentation, diagnosis, and treatment.

Authors:  M Galanter; R Castaneda; J Ferman
Journal:  Am J Drug Alcohol Abuse       Date:  1988       Impact factor: 3.829

Review 5.  Barriers to the care of persons with dual diagnoses: organizational and financing issues.

Authors:  M S Ridgely; H H Goldman; M Willenbring
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

6.  Substance abuse and bipolar affective disorder.

Authors:  S C Sonne; K T Brady; W A Morton
Journal:  J Nerv Ment Dis       Date:  1994-06       Impact factor: 2.254

7.  Diagnosis of alcohol use disorders in schizophrenia.

Authors:  R E Drake; F C Osher; D L Noordsy; S C Hurlbut; G B Teague; M S Beaudett
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

8.  Substance abuse in schizophrenia: service utilization and costs.

Authors:  S J Bartels; G B Teague; R E Drake; R E Clark; P W Bush; D L Noordsy
Journal:  J Nerv Ment Dis       Date:  1993-04       Impact factor: 2.254

9.  Psychotogenic drug use and neuroleptic response.

Authors:  M B Bowers; C M Mazure; J C Nelson; P I Jatlow
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

  9 in total
  2 in total

Review 1.  Dual diagnosis clients' treatment satisfaction - a systematic review.

Authors:  Sabrina J Schulte; Petra S Meier; John Stirling
Journal:  BMC Psychiatry       Date:  2011-04-18       Impact factor: 3.630

2.  Patient satisfaction with treatment for alcohol use disorders: comparing patients with and without severe mental health symptoms.

Authors:  Stacey L McCallum; Jane M Andrews; Matthew D Gaughwin; Deborah A Turnbull; Antonina A Mikocka-Walus
Journal:  Patient Prefer Adherence       Date:  2016-08-04       Impact factor: 2.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.